Clinical Autonomic Research

, Volume 10, Issue 3, pp 111–115 | Cite as

Autonomic dysfunction in Machado-Joseph disease assessed by iodine123-labeled metaiodobenzylguanidine myocardial scintigraphy

  • Toshinari Kazuta
  • Michiyuki Hayashi
  • Toshio Shimizu
  • Aya Iwasaki
  • Shigenobu Nakamura
  • Shunsaku Hirai
Research Paper

Abstract

Iodine123-labeled metaiodobenzylguanidine, a radioiodinated analogue of norepinephrine, is a tracer for evaluating sympathetic function. We used iodine123-labeled metaiodobenzylguanidine myocardial scintigraphy and sympathetic skin response to study autonomic nervous functions in 19 patients with Machado-Joseph disease (MJD) and 20 control subjects. Planar imaging of all the participants was done to evaluate myocardial scintigraphy. The ratio of average counts in the heart to average counts in the mediastinum was calculated for both early and delayed images, the latter of which reflects the cardiac neural uptake of the tracer. Single photon emission computed tomography also was done on 12 patients with MJD to examine regional tracer uptake to the heart. The mean ratio of counts in the heart to counts in the mediastinum in the delayed images was lower for the patients with MJD than for the control subjects (p <0.01). Abnormal sympathetic skin response was present in 6 patients with MJD whose mean ratio of counts in the heart to counts in the mediastinum was lower than that of patients with MJD who had normal sympathetic skin response (p <0.01). A single photon emission computed tomography study showed significantly lower accumulation of the tracer in patients with MJD than in the control subjects in the anterior lateral sectors predominantly innervated by sympathetic nerves but not in the inferior septal sectors reported to be under main innervation by parasympathetic fibers. These results show that MJD is accompanied by cardiac sympathetic dysfunction, as detected by iodine123-labeled metaiodobenzylguanidine myocardial scintigraphy, which appears to be correlated with sudomotor sympathetic dysfunction.

Key words

sympathetic nerve iodine123-labeled metaiodobenzylguanidine myocardial scintigraphy Machado-Joseph disease single photon emission computed tomography 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Wieland DM, Brown LE, Rogers WL, Worthington KC, Clinthorne NH, Otto CA, et al. Myocardial imaging with a radioiodinated norepinephrine storage analog.J Nucl Med 1981; 22:22–31.Google Scholar
  2. 2.
    Nakajo M, Shaprio B, Glowinak J, Sisson JC, Beiermaltes WH. Inverse relationship between cardiac accumulation of meta-[131]iodobenzylguanidine (I-131 MIBG) and circulating catecholamines in suspected pheochromocytoma.J Nucl Med 1983; 24: 1127–1134.Google Scholar
  3. 3.
    Dae MW, O'Connell W, Botvinick E, Abearn T, Yee E, Huberty JP, et al. Scintigraphic assessment of regional cardiac adrenergic innervation.Circulation 1989; 79:634–644.Google Scholar
  4. 4.
    Meriet P, Valette H, Dubois-Rand JL, Moyse D, Duboc D, Dove P, et al. Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure.J Nucl Med 1992; 33:471–477.Google Scholar
  5. 5.
    Mätysaari M, Kuikka J, Mustonen J, Tahvanainam K, Vannien E, Länstmies E, et al. Noninvasive detection of cardiac sympathetic nervous dysfunction in diabetic patients using [123I] Metaiodobenzyl guanidine.Diabetes 1992; 41:1069–1075.Google Scholar
  6. 6.
    Sisson JC, Shapiro B, Meyers I, Mallette S, Mangnen TJ, Wieland DM, et al. Metaiodobenzylguanidine to map scintigraphically the adrenergic nervous system in man.J Nucl Med 1987; 28:1625–1636.Google Scholar
  7. 7.
    Yoshita M. Differentiation of idiopathic Parkinson's disease from striatonigral degeneration and progressive supranuclear palsy using iodine-123 meta-iodobenzylguanidine myocardial scintigraphy.J Neurol Sci 1998; 155:60–67.Google Scholar
  8. 8.
    Takiyama Y, Sakoe K, Nakano I, Nishizawa M. Machado-Joseph disease: cerebellar ataxia and autonomic dysfunction in a patient with the shortest known expanded allele (56 CAG repeat units) of the MJD1 gene.Neurology 1997; 49:604–606.Google Scholar
  9. 9.
    Hara H, Sakai T, Koike F. Autonomic dysfunction in Joseph disease.J Auton Nerv Syst 1986; 23:284–288.Google Scholar
  10. 10.
    Yamamoto M, Kachi T, Sobue G. Pain-related and electrically stimulated somatosensory evoked potentials in patients with Machado-Joseph disease and multiple system atrophy.Intern Med 1997; 36:550–555.Google Scholar
  11. 11.
    Kazuta T, Hayashi M, Yoshita M, Hirai S. Iodine-123-labeled meta-iodobenzylguanidine myocardial scintigraphy evaluation of Machado-Joseph disease.Clin Neurol (Tokyo) 1998; 38:97–101.Google Scholar
  12. 12.
    Sollanki KK, Bornanji J, Moyes J, Mather SJ, Trainer PJ, Britton KE. A pharmacological guide to medicines which interferes with the biodistribution of radiolabeled meta-iodobenzylguanidine (MIBG).Nucl Med Commun 1992; 13:513–521.Google Scholar
  13. 13.
    Nakajima K, Taki J, Tonami N, Hisada K. Decreased 123I-MIBG uptake and increased clearance in various cardiac disease.Nucl Med Comm 1994; 15:317–323.Google Scholar
  14. 14.
    Gill JS, Hunter GJ, Gane G, Ward DE, Camm AJ. Heterogeneity of the human myocardial sympathetic innervation: in vivo demonstration by iodine-123-labeled metaiodobenzylguanidine scintigraphy.Am Heart J 1993; 126:390–398.Google Scholar
  15. 15.
    Yokota T, Matsunaga T, Okiyama R, Hirose K, Tanabe H, Furukawa T, et al. Sympathetic skin response in patients with multiple sclerosis compared with patients with spinal cord transection and normal controls.Brain 1991; 114:1381–1394.Google Scholar
  16. 16.
    Thames MD, Klopfenstein HS, Abboud FM, Mark AAL, Walker JL. Preferential distribution of inhibitory cardiac receptors with vagal afferents to the inferoposterior wall of the left ventricle activated during coronary occlusion in the dog.Circ Res 1978; 43:512–519.Google Scholar
  17. 17.
    Kinoshita A, Hayashi M, Oda M, Tanabe H. Clinical study of the peripheral nervous system in Machado-Joseph disease.J Neurol Sci 1995; 130:48–58.Google Scholar

Copyright information

© Lippincott Williams & Wilkins 2000

Authors and Affiliations

  • Toshinari Kazuta
    • 1
  • Michiyuki Hayashi
    • 2
  • Toshio Shimizu
    • 1
  • Aya Iwasaki
    • 1
  • Shigenobu Nakamura
    • 3
  • Shunsaku Hirai
    • 1
  1. 1.Department of NeurologyTokyo Metropolitan Neurological HospitalTokyoJapan
  2. 2.Department of NeurologyOhtsu Municipal HospitalOhtsuJapan
  3. 3.The Third Department of Internal MedicineHiroshima University School of MedicineHiroshimaJapan

Personalised recommendations